1. Emmett M, Fenves AZ, Schwartz JC. Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM, editors. Approach to the patient with kidney disease. Brenner and Rector's The Kidney. 2011. 9th ed. Philadelphia: WB Saunders;844–866.
2. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009. 150:604–612.
3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002. 39:2 Suppl 1. S1–266.
4. Lee SY, Kwak DW. Clinical significance of foamy urine. J Pusan National University Hospital. 2009. 26:357–363.
Article
5. Yap YS, Chi WC, Lin CH, Wu YW, Liu YC. Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study. Int Urol Nephrol. 2012. [Epub ahead of print].
Article